US 12018015
Methods and compositions for targeting PD-L1
granted A61KA61K31/506A61K31/5377
Quick answer
US patent 12018015 (Methods and compositions for targeting PD-L1) held by Aligos Therapeutics, Inc. expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/506, A61K31/5377, A61K31/658, A61K45/06